Acyclovir - NDC Database (Page 15)
557 records found
Start a Discussion
49349-269 May 09, 2011
Acycycloguanosine 200 mg Oral Capsule by Remedyrepack Inc.
49349-375 Aug 23, 2012
Acycycloguanosine 400 mg Oral Tablet by Remedyrepack Inc.
49349-377 Jul 14, 2011
Acycycloguanosine 200 mg Oral Capsule by Remedyrepack Inc.
49349-429 Jul 28, 2011
Acycycloguanosine 400 mg Oral Tablet by Remedyrepack Inc.
49349-886 Apr 09, 2013
Valacyclovir 1 Gm Oral Tablet by Remedyrepack Inc.
50090-0596 Oct 22, 2009
Acyclovir 200 mg Oral Capsule by A-s Medication Solutions
50090-0637 Mar 13, 2006
Acyclovir 800 mg Oral Tablet by A-s Medication Solutions
50090-0643 Jun 09, 2007
Acyclovir 400 mg Oral Tablet by A-s Medication Solutions
50090-2381 Oct 22, 2009
Acyclovir 200 mg Oral Capsule by A-s Medication Solutions
50090-3250 Sep 10, 2014
Acyclovir 400 mg Oral Tablet by A-s Medication Solutions
50090-3254 Sep 10, 2014
Acyclovir 400 mg Oral Tablet by A-s Medication Solutions
50090-3795 Sep 10, 2014
Acyclovir 800 mg Oral Tablet by A-s Medication Solutions
50090-3902 Aug 17, 2017
Acyclovir 200 mg Oral Capsule by A-s Medication Solutions
50090-5610 May 27, 2021
Acyclovir 200 mg Oral Capsule by A-s Medication Solutions
50090-5739 Oct 15, 2016
Acyclovir 200 mg Oral Capsule by A-s Medication Solutions
50090-6335 Aug 15, 2020
Acyclovir 800 mg Oral Tablet by A-s Medication Solutions
50090-6561 Jul 31, 2017
Acyclovir 50 mg/g Topical Ointment by A-s Medication Solutions
50090-6578 Jun 20, 2023
Acyclovir 800 mg Oral Tablet by A-s Medication Solutions
50090-6844 Nov 29, 2013
Acyclovir 400 mg Oral Tablet by A-s Medication Solutions
50090-7216 Aug 23, 2019
Acyclovir 200 mg Oral Capsule by A-s Medication Solutions
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
